Though somewhat limited, these data do indicate a potential for unreasonable adverse endocrine disruption in humans and ...
In February, a federal district court in Arizona vacated the only three post-emergent formulations of dicamba on the marketplace, marking the second time post-emergent dicamba registrations were vacat ...